Skip to content

Brain/Neural Hand Exoskeleton Control for Restoration of Bimanual Tasks

Restoration of Bimanual Activities of Daily Living Using a Brain/Neural Hand Exoskeleton (B/NHE) in Hand Paralysis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04440709
Enrollment
10
Registered
2020-06-22
Start date
2020-06-30
Completion date
2020-10-31
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury, Stroke

Brief summary

This study investigates whether spinal cord injury and stroke survivors (n=10) are able to operate a brain/neural hand exoskeleton (B/NHE) based on electroencephalography (EEG) and electrooculography (EOG) for restoration of bimanual activities of daily living (ADLs). To assess bimanual ADLs, the Berlin Bimanual Task Assessment (BEBITA) will be applied. Improvements in BEBITA will be evaluated with and without B/NHE use.

Interventions

DEVICEBrain/neural hand exoskeleton (B/NHE)

The brain/neural hand exoskeleton restores hand motor function by translating user's intention into grasping motions

Sponsors

Charite University, Berlin, Germany
CollaboratorOTHER
Reutlingen University
CollaboratorUNKNOWN
Hochschule der Medien
CollaboratorUNKNOWN
University of Stuttgart
CollaboratorOTHER
University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
No

Inclusion criteria

(Stroke): * single ischemic or hemorrhagic insult with subcortical lesion (medullary canal, internal capsula, pedunculi cerebri) * interval since stroke at least 6 months * substantial motor deficit with: * Medical Research Council (MRC) -score of less than 2 out of 6 possible points (0=no activity; 1=visible contraction without motor effect; 2=movements with elimination of gravity; 3=movements against gravity; 4=movements against weak resistance; 5=normal force) * Fugl-Meyer Test (upper extremity) of less than 31 points, no to little mobility Inclusion Criteria (Spinal Cord Injury): * cervical spinal cord injury, height C5-C6 * interval after spinal cord injury at least 6 months * substantial motor deficit with American Spinal Cord Association (ASIA) -Classification B or C (A=no muscle function/sensitivity below the spinal cord injury; B=no muscle function, limited sensitivity present; C=low non-relevant muscle function, sensitivity present; D=functionally relevant muscle functions present; E=fully preserved or restored functions)

Exclusion criteria

(Stroke and Spinal Cord Injury): * Alcohol or drug problem (regular consumption of more than 2 alcoholic beverages per day, or taking illegal drugs) * currently undergoing neurological or psychiatric treatment based on a secondary diagnosis * Severe and uncontrollable medical problems: * Non-adjusted malignant high blood pressure, World Health Organization (WHO) Hypertension Grade II * non-adjustable diabetes mellitus, HbA1c \> 58 mmol/mol * renal failure, from KDIGO glomerular filtration rate (GFR) category G3b (moderate to severe impairment) * Liver failure, Child-Pugh stages B and C * Heart failure New York Heart Association (NYHA) grade III-IV * malignant tumor disease * severe arrhythmia in need of treatment * severe oedemas * severe arthritis * serious cognitive impairment (minimum status below 23 points) * Severe spasticity (Ashworth grade ≥ 4) * Pregnancy * Bilateral motor deficit (in stroke patients)

Design outcomes

Primary

MeasureTime frame
Change in Berlin Bimanual Task Assessment (BEBITA) scoreHand function will be assessed twice on the same day. Once before the hand exoskeleton is applied (absence of the assistive device) and once after the brain-controlled hand exoskeleton was attached to the patients' hand and arm.

Countries

Germany

Contacts

Primary ContactSurjo R. Soekadar, MD
surjo.soekadar@uni-tuebingen.de+49-163-1644889

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026